
Dr. Michael C. Merwin
- Gender: Male
- Experience: 39 years
- Sole propriator: No
- NPI: 1326158445
Dr. Michael C. Merwin MD
Pathologist
He is located at 2767 Olive Highway in Oroville, CA 95966. Can help patients with the following: Benign Tumor, Cyst, Infarction, Skin Biopsy. His National Provider Identifier (NPI) number is 1326158445. Appointment can be made via the phone number (530) 532-8320.
Conditions treated
Dr. Michael Charles Merwin, being an pathologist, treats the following conditions. Please be advised that this list may not be complete. For the full list of conditions treated, consult directly with Dr. Michael C. Merwin.
- Benign Tumor
- Cyst
- Infarction
- Skin Biopsy
Procedures Performed by Dr. Michael C. Merwin
Insurances Accepted by Dr. Michael C. Merwin
- Medicare
Looking for more Pathologists?
- Gender: Male
- Address: 9901 Medical Center Drive Rockville, 20850, MD
- Gender: Female
- Address: Suite 1105 200 South 10th Street McAllen, 78501, TX
- Gender: Female
- Address: Suite 107/108 2904 Westcorp Boulevard Southwest Huntsville, 35805, AL
- Gender: Male
- Address: MC0008 Room TW055 5841 South Maryland Avenue Chicago, 60637, IL
- Gender: Female
- Address: 3600 Northwest Samaritan Drive Corvallis, 97330, OR
- Gender: Female
- Address: 5000 West National Avenue Milwaukee, 53295, WI
- Gender: Male
- Address: #302 C/O Drives Hill and Chapnick INC. 7580 Auburn Road Concord, 44077, OH
- Gender: Male
- Address: 1125 West Jefferson Street Franklin, 46131, IN
- Gender: Female
- Address: 901 Macarthur Boulevard Munster, 46321, IN
- Gender: Male
- Address: 500 University Drive Hershey, 17033, PA
Questions & Answers
What conditions does Dr. Michael Charles Merwin treat?
Dr. Michael Charles Merwin provides treatment for Benign Tumor, Cyst, Infarction, Skin Biopsy.
Where can you meet with Dr. Michael Charles Merwin?
Dr. Michael Charles Merwin's office is located at 2767 Olive Highway in Oroville, CA 95966.
Does Dr. Michael Charles Merwin accept patients with Medicare?
Yes, Dr. Michael Charles Merwin accepts patients with Medicare.